OPKO Health (OPK) Stock Price, Quote, News & History | Benzinga

SPY778.57+0.60%QQQ751.38+0.51%BTC/USD83,452.01+0.64%DIA516.21+0.89%GLD384.50+1.55%TLT77.97+0.12%

OPKO Health Inc (OPK) Stock Price, Quote, News & History

OPKNASDAQ

Trade with Public

Trade with Public

$1.38

0.010.73%

Last update: Oct 9, 5:28 PM

$1.35

-0.02-1.46%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$1.38

Close

$1.38

Volume / Avg.

1.09M / 3.32M

Day Range

$1.35 - $1.35

52 Wk Range

0.98 - 1.75

Market Cap

$1.02B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

30

Short Interest

8.57%

Days to Cover

14.94

Recent OPKO Health, Inc. News

Crude Oil Down Over 5%; Boeing Shares Rise After Q2 Results

US stocks trade higher, Dow up 1% on Tuesday. Boeing gains 5% after reporting Q2 results. Kiniksa Pharma, OPKO Health, Itron, up over 20%.

Avi Kapoor

Sherwin-Williams Posts Upbeat Q2 Earnings, Joins Itron, Armstrong World And Other Big Stocks Moving Higher On Tuesday

U.S. stocks mixed, Dow Jones up 300 points. Shares of Sherwin-Williams rose 7.8% after reporting better-than-expected earnings and raising FY26 guidance.

Avi Kapoor

Why Celestica Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket

Celestica Inc (NYSE: CLS) exceeded analyst estimates with quarterly earnings of $2.54 per share and revenue of $4.7 billion, leading to a 4.7% jump in pre-market trading. Other top gainers include C3is, INLIF, and Polar Power. FIEE and KIDZ were among the top losers.

Avi Kapoor

This Purple Innovation Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

Wall Street analysts changed outlook on top names. See all rating changes on analyst ratings page. PRPL, OPK, BF.B, MELI, RPD stocks downgraded.

Avi Kapoor

This Rocket Lab Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-123.38M

Investing Cash Flow (TTM)

206.34M

Financing Cash Flow (TTM)

-52.73M

Free Cash Flow (TTM)

-134.02M

Capital Expenditure (TTM)

-10.64M

Net Change in Cash (TTM)

30.23M

Analyst Trends and Forecast

1

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.13B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

1.81

PB Ratio (TTM)

0.86

Earnings Yield % (TTM)

-5.13%

Earnings Yield % (FWD)

-19.05%

EV / EBITDA (TTM)

20.33

Price / EBITDA (TTM)

19.38

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.59

Company Debt

Total Debt

$349.05M

LT Debt

$338.49M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$41.41M

Total Cash

$300.76M

Debt to Equity

0.34

Issuance of Debt (TTM)

-$8.38M

Repayment of Debt (TTM)

-$40.74M